The grasshopper median neuroblast (MNB) is a multipotent progenitor cell that produces neurons and midline glia in distinct temporal phases. The MNB generates pioneer neurons during its first few divisions, and then switches to production of midline glial precursors. After the glia have been produced, the MNB reverts to generating neurons. We have investigated the molecular mechanism underlying the transition from glia production back to neuron production in the MNB lineage. Results: We report evidence that this second transition in the MNB lineage is triggered by the activation of cAMPdependent protein kinase (PKA). PKA is a heterodimer of a catalytic (PKA-C) and a cAMP-binding regulatory (R) subunit. The R subunit dissociates from PKA-C on binding cAMP, and free PKA-C then translocates into the nucleus. Nuclear localization of PKA-C can thus be used as an indicator of PKA activation within a cell. We have found that PKA-C is translocated into the nucleus at the time of the second switch in the MNB lineage. When PKA is prematurely activated in the MNB by microinjection of purified PKA-C, or by pharmacological agents that elevate intracellular cAMP levels, the glialto-neuronal cell-fate switch takes place prematurely. Inhibition of PKA activity by microinjection of a peptide inhibitor, or by a non-hydrolyzable cAMP analog, blocks the glial-to-neuronal switch. Conclusions: Our results imply that elevation of cAMP in the MNB, and the resultant activation of PKA, is likely to be a trigger for the glial-to-neuronal cell-fate transition within the MNB lineage.
Introduction
The neurons of the embryonic insect central nervous system (CNS) are derived from a segmentally repeated array of neuroblasts. Each neuroblast divides asymmetrically to produce a lineage of ganglion mother cells, which divide once symmetrically to produce two neurons. Some neuroblasts also produce glial progeny [1, 2] . CNS neurons extend growth cones along stereotyped pathways, leading to the formation of a ladder-like axonal array with paired longitudinal tracts and two commissural tracts per segmental neuromere. The overall structure of the embryonic CNS is conserved between the grasshopper Schistocerca, a species with relatively large neurons, and the fruit fly Drosophila melanogaster, which has smaller neurons (for reviews see [3] [4] [5] ). In the grasshopper, neuroblast lineages can be analyzed by microinjecting neuroblasts in cultured embryos with tracer dyes, and visualizing dye-labeled progeny produced during the culture period [2, 6] (Fig. 1 ).
The grasshopper median neuroblast (MNB) lineage has been examined in detail using these methods. The MNB is a multipotent progenitor cell that produces both neurons and midline glia. The axons of neuronal MNB progeny extend anteriorly along the median fiber tract and bifurcate in one of the two commissures. The midline glial progeny enwrap the commissures and ensheath the cell bodies of MNB progeny neurons. Neurons and glia are produced in distinct temporal phases. The MNB generates neuronal ganglion mother cells in its first few divisions, then produces glial precursors for approximately eight divisions, after which it again begins making ganglion mother cells [2] .
The first transition in the MNB lineage, from the generation of neuronal ganglion mother cells to production of glial precursors, requires the function of the engrailed segmentation gene. The engrailed gene encodes a homeodomain transcription factor that is expressed by all newly born MNB progeny, but not by the MNB itself. When engrailed expression is inhibited in the lineage by microinjection of antisense-engrailed oligodeoxynucleotides into the MNB nucleus, progeny born after the transition period take on neuronal identities, and no glia are produced [7] .
To understand the molecular mechanisms of cell-fate determination within the MNB lineage, we are attempting to identify signaling pathways that affect the two temporally regulated cell-fate switches. In this paper, we focus on the role of a signaling pathway involving elevation of intracellular cAMP concentration and activation of cAMP-dependent protein kinase (protein kinase A; PKA). PKA is a cytoplasmic heterodimer consisting of a catalytic subunit (PKA-C) and a cAMP-binding regulatory subunit (R). When cAMP binds to the R subunit, it dissociates from the C subunit. Free PKA-C is active as a kinase, whereas the heterodimeric holoenzyme is inactive. When elevated cAMP levels are Fig. 1 . Tracing lineages in grasshopper embryo cultures. A cartoon of the ventral portion of a grasshopper embryo is shown at the left. The A3 segment is boxed, and the two cartoons at the right show enlargements of this segment, viewed from the dorsal side before and after culturing. The round cells are neuroblasts, and in this example the MNB (red) is filled with a tracer dye at the beginning of the culture period. During the culture, the axon scaffold of the CNS develops (green), and the MNB produces neuronal and glial progeny. MNB progeny neurons (red) extend bifurcating axons along commissural pathways. The glia (not shown) migrate anteriorly, and eventually enwrap the commissures and ensheath the MNB cluster. maintained in a cell for a prolonged period of time, PKA-C translocates into the nucleus, where it can phosphorylate transcription factors [8] [9] [10] [11] [12] . Nuclear localization of PKA-C can also occur in response to a pulse of cAMP if the free R subunit is rapidly degraded [13] . Nuclear localization of PKA-C thus indicates that PKA has been activated, and that intracellular cAMP levels were recently elevated.
In this paper, we report that PKA-C translocates into the MNB nucleus at the time of the second cell-fate transition, during which the MNB switches from generation of glial precursors to production of neuronal ganglion mother cells. The switch in progeny cell fates can be blocked by inhibiting PKA activity in the MNB during the glial production phase. Furthermore, increasing PKA activity in the MNB during the glial production phase causes the switch to neuronal production to occur prematurely. These results indicate that elevation of intracellular cAMP levels in the MNB, probably in response to a temporally controlled extracellular signal, is likely to be a trigger for the glial-to-neuronal cell-fate switch within this lineage.
Results
Nuclear translocation of PKA in the MNB correlates with a switch in progeny cell fates To investigate whether PKA is activated and translocated into the nucleus during the MNB lineage, we stained grasshopper embryos with an antiserum (obtained from Daniel Kalderon, Columbia University) against the catalytic subunit of Drosophila PKA [14, 15] . Western blotting experiments showed that the PKA-C antiserum recognizes a single protein species in grasshopper embryos that migrates slightly slower than the corresponding 40 kD band from Drosophila embryos (data not shown). Grasshopper embryos between 28 % and 55 % of development were stained with the PKA-C antiserum, and PKA-C expression was visualized using fluorescent secondary antibodies and confocal microscopy. The PKA-C antiserum stains the cytoplasms of all cells, including neuronal processes (Fig. 2a-c) .
When PKA-C was examined in the MNB, it was found to be cytoplasmically localized from the MNB's birth at 27-28 % of development to 37 % (normalized to the T3 segment; see Fig. 2 legend) . The MNB has a bilobed nucleus, the outline of which is defined by the cytoplasmic PKA-C staining (Fig. 2a) . At about 37 % of development, PKA-C begins to translocate into the MNB nucleus. From 39-45% of development, PKA-C fills the entire MNB, and its concentrations in the nucleus and cytoplasm appear nearly equal (Fig. 2b) . This change in PKA-C localization can also be visualized using horseradish peroxidase (HRP) immunohistochemistry and Nomarski optics (Fig. 2e-f) . Duringthe period in which PKA-C fills the cell, the MNB nucleus retains its characteristic shape. This can be visualized by staining for 13-tubulin. After 45 % of development, PKA-C staining in the nucleus rapidly diminishes, and by 47 % it again appears completely cytoplasmic (data not shown).
The nuclear translocation of PKA-C is specific to the MNB. PKA-C localization was examined in all of the lateral neuroblasts, and it was found to be primarily cytoplasmic (Fig. 2d) . It is also cytoplasmically localized in MNB progeny neurons during the same period in which it fills the MNB nucleus (Figs. 2b,f) . To examine whether nuclear translocation of PKA-C correlates with elevation of intracellular cAMP in this system, we treated cultured embryos with isobutylmethylxanthine (IBMX) or forskolin, which elevate cAMP by inhibiting cAMP phosphodiesterase (IBMX) or activating adenylyl cyclase (forskolin). These treatments produced nuclear localization of PKA-C throughout the embryo. Figure 2g shows PKA-C filling all of the MNB progeny in an IBMX-treated embryo.
We used confocal microscopy to quantify the nuclear translocation of PKA-C and determine its temporal relationship to developmental transitions within the MNB lineage. The levels of PKA-C in the nuclei and cytoplasm of MNBs at various stages of development were determined by quantification of fluorescence densities in optical sections generated by confocal microscopy. A graph of these results (Fig. 3) shows that PKA-C is present at high levels in the MNB nucleus between approximately 39 % and 45 % of development.
Effects of prematurely elevating protein kinase A activity
The second developmental transition in the MNB lineage, in which the MNB switches from producing glia expand dorsally and laterally from the cluster and pile up in a disorganized manner. They express high levels of the 8B7 antigen on their cell bodies, which is characteristic of immature neurons (see [7] ). In contrast, 8B7 antigen expression in the MNB clusters of control embryos (Fig.  4a) is restricted to the median fiber tract at this stage. The ectopic neurons also express a cytoplasmic neuronal marker recognized by antibodies against the elav gene product [16] (data not shown). Fig. 3 . Quantification of PKA-C translocation in the MNB during development. The levels of PKA-C in the nuclei and cytoplasm of MNBs were determined by quantifying fluorescence densities in optical sections at the level of the cytoplasmic projection into the MNB nucleus. The nuclear/cytoplasmic expression ratio (translocation ratio) is plotted against developmental percentage. A total of 81 MNBs were analyzed. Error bars indicate standard deviations. Most of the error is not due to variability in quantifying fluorescence densities, because repeat measurements for an individual MNB differ by less than 10 %. Errors are likely to appear because of the difficulty in precisely determining the age' of an MNB. There is often significant asynchrony between the apparent developmental age of an MNB and the overall development age of the embryo, which is used to establish developmental percentages. The graph shows that translocation involves an approximately three-fold change in the relative levels of PKA-C in the nucleus and cytoplasm, and that PKA-C is localized to the nucleus to a maximal extent between 39 % and 45 %. The graph also indicates that nuclear translocation in the population of sampled MNBs takes place over an interval of 3 % of development (14 hours). The translocation event in an individual MNB, however, might occur within a shorter time period. The difference in PKA-C localization between MNBs at 35 % and 39 % of development is statistically significant (p=7.32x10 -5 by the Student's t-test; see Materials and methods for details).
to generating neuronal ganglion mother cells [2] , is coincident with completion of PKA-C nuclear translocation (-39 % of development). This correlation suggests that cAMP elevation and PKA activation could be involved in changing the fates of MNB progeny. To evaluate this, we artificially elevated cAMP levels and PKA activity in the MNB during the glial production phase, before the time when the switch to neuronal production normally occurs. This was done by culturing 30-35 % embryos in the presence of IBMX, forskolin, or a mixture of the two. During the 72 hour culture period, embryos advance through 10-15 % of development, so the transition from glial and neuronal production can be readily examined.
Low concentrations of IBMX and/or forskolin did not affect the overall pattern or rate of CNS development, but both compounds produced the same specific change in the MNB lineage. In IBMX-treated embryos, MNB clusters contain a greater than normal number of cells that express the neuronal marker recognized by the monoclonal antibody 8B7 (Fig. 4a-c) . These cells Quantification of neuronal numbers in IBMX/forskolintreated segments in which culturing was begun at or before 32 % of development indicates that their MNB clusters contain 24+4 (n=22) neurons. Such segments develop to the equivalent of 43-44 % of in vivo development. MNB clusters in cultured control segments, or in segments that developed to 43 % in vivo, have about 10 neurons at this stage [2, 7] , so -14 extra neurons are generated as a result of elevation of intracellular cAMP at the beginning of the glial production phase.
IBMX/forskolin treatments elevate cAMP levels throughout the embryo. To evaluate whether their effects on the MNB lineage were due to changes in PKA activity within the MNB itself, we injected MNB nuclei at 31-32 % of development with purified mammalian PKA-C. The PKA-C-injected MNBs produced dorsally expanded clusters that were indistinguishable from those observed in IBMX/forskolin-treated embryos (data not shown; see Fig. 5b ).
We have previously shown that inhibition of engrailed expression within the MNB lineage blocks the first cellfate transition in the MNB lineage, during which the MNB switches from generation of neuronal ganglion mother cells to production of glial precursors. When engrailed expression is inhibited, no glia are produced and the MNB continues to generate neurons. MNB clusters in engrailed-inhibited segments are dorsally and laterally expanded, and have a very similar appearance to those in IBMX/forskolin-treated embryos [7] . We thus examined whether the effect of IBMX/forskolin treatment might involve repression of engrailed expression. Figure 4c shows an IBMX-treated embryo double stained for 8B7 antigen and engrailed protein. Engrailed-expressing cells (gray) can be visualized within the expanded MNB clusters in this embryo. A comparison of engrailed-staining intensities between treated and control embryos (see [2, 7] ) indicated that the level of engrailed expression in MNB progeny neurons is not significantly reduced by IBMX/ forskolin treatment.
The dorsal and lateral expansion of MNB clusters produced by inhibition of engrailed expression is due to the presence of extra neurons and absence of the glia that normally ensheath the cluster. We examined whether midline glia are affected by IBMX/forskolin treatment, by staining embryos for the midline glial marker annulin [17, 18] . Figure 4d -e show control and IBMX-treated embryos double stained for annulin and 8B7 antigen. In Fig. 4 . Effects of elevating intracellular cAMP on development of the MNB lineage. (a) Two segments of a cultured control embryo stained for the neuronal marker recognized by the 8B7 monoclonal antibody (a cytoplasmic antigen present in all neurons) using HRP immunohistochemistry. In all panels, the neurons of the MNB cluster are indicated by an arrow, and the anterior and posterior commissures are indicated by a and p, respectively. Note that 8B7 antigen expression on control MNB progeny neurons is largely restricted to the median fiber tract, which extends anteriorly from the cluster to the commissures. (b) Two segments of an embryo cultured in the presence of 50 jIM IBMX. Note the larger number of neurons in the MNB clusters. The clusters are laterally expanded and disorganized, and 8B7 antigen expression is high on neuronal cell bodies. (c) Two segments of an embryo cultured in the presence of 50 iM IBMX and double stained for both 8B7 antigen (brown) and engrailed (gray). Engrailed-expressing cells are visible in both of the expanded MNB clusters. Engrailed staining can also be visualized in other neuronal groups, such as the EC cells [7] at the junctions between the posterior commissure and the connectives. (d) A segment of a cultured control embryo double stained for the midline glial marker annulin (blue-black) and 8B7 antigen (brown). Note the large number of midline glia anterior to the MNB cluster (see [2] ). 8B7 staining is weak in this segment. (e) A segment of an embryo cultured in the presence of 50 I.M IBMX, double stained for the midline glial marker annulin and for 8B7 antigen. The faint staining along the midline is due to residual annulin expression in mesectodermal cells (see [7, 17] control embryos, annulin is expressed on a large number transition by inhibiting PKA in the MNB. This was of midline glia (31 per segment) [2] that extend anteridone by injecting the MNB at 35 % with a therorly along the midline and ensheath the MNB cluster. In mostable peptide inhibitor of PKA (the Walsh inhibitor, IBMX-treated embryos, there is little annulin expression PKI) [19] or by bathing 35-37 % embryos in a cell-perand no midline glia can be visualized. meable PKA inhibitor, the drug Rp-cAMPS [20] . The embryo shown in Fig. 4f was treated with Rp-cAMPS Effects of inhibiting protein kinase A activity and stained for annulin and 8B7 antigen at the end of the Thus, increasing PKA activity in the MNB at 30-35 % culture period (the equivalent of -48% of development of development causes the second developmental transiin vivo). In this segment, the cluster of MNB progeny tion in the lineage -the switch from producing glial neurons is smaller than in control embryos cultured until precursors to generating neuronal ganglion mother cells the same time point, suggesting that fewer neurons are -to occur prematurely. This transition normally occurs produced when PKA is inhibited (see below for quantifiat 39-40 % of development, the time when PKA-C becation). The glial network in this segment may be denser comes nuclearly localized. We investigated whether this than in control segments ( Fig. 4d ; all glia are present by increased PKA activity is required for the second cell fate 43 % of development).
To evaluate further whether midline glia and neurons are altered by inhibition of PKA, we used confocal microscopy to visualize a rhodamine-dextran lineage tracer within MNB lineages. Tracer dye was injected into MNBs at the beginning of the culture period. In a control lineage ( Fig. 5a ; see also [2, 7] ), neuronal cell bodies, axons and midline glia can be visualized. In segments in which the MNB nucleus was injected with purified PKA-C together with tracer dye (Fig. 5b) , all MNB progeny were localized to the cluster. No glia anterior to the cluster are observed. This pattern of dye labeling is identical to that seen when engrailed expression is inhibited [7] . When Walsh inhibitor and tracer dye were coinjected, glia were produced, and they migrated posteriorly to a greater extent than is normally observed (Fig. 5c ).
Bathing embryos in R-cAMPS produced similar effects on dye-labeled lineages (data not shown).
When an MNB was injected with Walsh inhibitor and the embryo cultured in the presence of IBMX, dye-filled glia migrated both posteriorly and anteriorly from the injected segment into the adjacent segments, which lack glia ( Fig. 5d-e ). These observations show that Walsh inhibitor injections into the MNB block the effect of IBMX by rescuing the production of midline glia in the injected segment. This indicates that increased PKA activity in the MNB is responsible for the lack of glia in IBMX-treated segments. The density of glial labeling relative to control segments does not appear to be reduced by migration into adjacent segments, suggesting that extra glia are generated in Walsh-inhibitor-injected segments.
We used confocal microscopy to visualize annulin and 8B7 antigen simultaneously in control, Walsh-inhibitorinjected, and R -cAMPS-treated segments, in order to determine whether the relative numbers of midline neurons and glia are altered by inhibition of PKA activity. The MNB in the posterior segment of Figure 5f was injected with Walsh inhibitor. Comparison of this segment with the control segment anterior to it shows that there are fewer red, round cell bodies at the position of the MNB cluster in the Walsh-inhibitor-injected segment. The green glial sheath is much narrower than usual at this point (arrow), suggesting that many of the neurons that it would normally surround are missing. At the end of the culture period, 8 + 1.6 (n=17) neurons are present in MNB clusters of segments injected with Walsh inhibitor at 35 %. These segments developed to approximately 48 % in culture. Control segments cultured from 35 % had 15 1.4 (n=16) neurons within their MNB clusters, similar to the number of these neurons found in segments that developed to 48 % in vivo [2] .
The intensity of green glial labeling around and immediately anterior to the MNB cluster is brighter in the Walsh-inhibitor-injected segment than in the adjacent control segment (Fig. 5f ). This suggests that there may be more glia in segments in which PKA activity is inhibited. This increase in annulin staining intensity in Developmental percentages (normalized to the T3 segment) are indicated at the top, as is the period during which embryos are cultured and that during which nuclear localization of PKA normally occurs. The top line shows the normal pattern of development, in which the MNB generates neurons (red), then glia (elongated green cells), then reverts to production of neurons. When engrailed expression is inhibited, no glia are generated, and extra neurons are produced that pile up in a disorganized manner. PKA-C translocation may be impaired in engrailed-inhibited segments (indicated by hatching of the MNB nucleus). The same effect is produced by premature activation of PKA. When PKA is inhibited, glia are generated, but the second phase of neuronal production does not occur. Extra glia may be produced during this phase.
Walsh-inhibitor-injected segments was reproducibly observed. Because of the irregular shapes and tight packing of midline glia, however, we have not been able to count glia accurately in either annulin-stained or dyelabeled lineages. Thus, we cannot definitively determine whether the number of glia has increased as a result of inhibition of PKA.
Overriding effect of inhibiting engrailed expression
Inhibition of engrailed expression in newly-born MNB progeny, and premature elevation of PKA activity in the MNB (near the beginning of the glial production phase), both cause the generation of extra neurons at the expense of midline glia. Inhibition of PKA activity in the MNB reduces neuronal production and may increase the number of midline glia. To examine the epistatic relationships between these phenotypes, we inhibited both engrailed expression and PKA activity by coinjecting MNB nuclei at 32 % with antisense-engrailed oligodeoxynucleotides and Walsh inhibitor. Figure 5g shows a lineage produced from such an MNB. An increased number of dyelabeled, 8B7-positive cells are observed, and these expand laterally and dorsally from the cluster in the same manner as in a lineage in which only engrailed expression is inhibited [7] . Similar results were observed when antisense-, engrailed oligonucleotide-injected segments were cultured in the presence of Rp-cAMPS (data not shown; see Materials and methods).
We also examined whether inhibition of engrailed expression at 32-35 % causes premature nuclear translocation of PKA-C. Embryos in which the MNB had been injected with antisense-engrailed oligodeoxynucleotides were stained with the PKA-C antiserum during the glial production phase, and PKA-C was observed to be cytoplasmically localized (data not shown). Thus, the production of extra neurons in engrailed-inhibited segments is unlikely to be due to premature elevation of intracellular cAMP levels.
Discussion

Cell fate determination in the grasshopper MNB lineage
The grasshopper MNB generates neuronal and glial progeny in distinct temporal phases. Like other neuroblasts, the MNB divides regularly every 1 % of development (-5 hours) [21] . The first divisions produce three or four ganglion mother cells, and their neuronal progeny (six to eight neurons) extend axons that pioneer the bifurcating pathways of the median fiber tract. The MNB then generates midline glial precursors for approximately eight divisions. These migrate anteriorly and divide to form groups of commissural and sheath glia. There are approximately 24 axonal midline glia and seven glia that ensheath the MNB cluster in each segment. At 39-40 % of development, the MNB switches back to production of neuronal ganglion mother cells [2] . These divide to produce at least three classes of midline neurons [22] [23] [24] [25] .
The homeobox transcription factor encoded by the engrailed gene is required for the first cell-fate transition in the lineage, in which the MNB switches from generation of ganglion mother cells to production of glial precursors. Inhibition of engrailed expression in newly born MNB progeny causes them to adopt neuronal rather than glial fates [7] .
In this paper, we have reported evidence that an intracellular signaling pathway involving elevation of the MNB's intracellular cAMP level is likely to be a trigger for the second cell-fate transition, in which the MNB ceases to generate glial precursors and resumes production of neuronal ganglion mother cells. PKA is the major effector for cAMP in most cell types, and it translocates into the nucleus in response to cAMP elevation [8] [9] [10] [11] [12] . This is because PKA holoenzyme is excluded from the nucleus, but free C subunit can diffuse into the nucleus after the R subunit dissociates upon binding to cAMP [26] . We have found that PKA-C becomes nuclearly localized in the MNB by 39 % of development, the time of the glialto-neuronal transition in the lineage (Figs 2 and 3 ). The MNB is the only cell in the CNS in which we have clearly observed nuclearly localized PKA-C, suggesting that signaling pathways requiring nuclear PKA activity are not widely used during early CNS development.
When PKA activity is prematurely elevated in the MNB (at 30-35 % of development) by microinjection of purified PKA-C, or by treating cultured embryos with low concentrations of IBMX or forskolin, the second neuronal production phase also occurs prematurely (Fig. 4) . The total number of neurons in MNB clusters in which PKA activity is elevated at the beginning of the glial production period is consistent with the uninterrupted production of neuronal ganglion mother cells during the entire culture period.
The normal glial-to-neuronal transition that occurs at 39-40 % of development requires elevation of PKA activity. This was shown by microinjecting the MNB with Walsh inhibitor at 35 % of development. In Walshinhibitor-injected segments, a smaller than normal number of MNB cluster neurons are present at the end of the culture period (Fig. 5) . The same phenotype is produced by bathing cultured embryos in Rp-cAMPS, a cell-permeable PKA inhibitor. The number of MNB cluster neurons in these segments (which developed to 48% of development) is approximately the same as that observed at 35 % of development in vivo [2] . These data suggest that neuronal ganglion mother cells are not generated after the glial production phase in PKA-inhibited segments. PKA inhibition does not simply prevent the generation of MNB progeny, because if Walsh inhibitor or R -cAMPS is introduced at the beginning of the glial production phase (32 % of development), the MNB generates a normal complement of midline glia (data not shown).
If PKA inhibition blocks the glial-to-neuronal transition in the MNB lineage, one would also predict that extra midline glia would be generated in PKA-inhibited segments. Our data suggest that this may be the case (Fig.  5d-f ), but we are unable to count midline glia accurately because of their tight packing and irregular shapes. Another problem with the assessment of midline glial numbers is that the divisions of glial precursors may not be autonomously determined, and could be regulated by the number of glial positions that require filling. When one MNB is injected with Walsh inhibitor and the embryo cultured in the presence of IBMX, glia migrate posteriorly and anteriorly from the injected segment into the adjacent segments, in which all glial positions are vacant ( Fig. 5d-e) : In these embryos, extra glia are likely to be generated in the Walsh-inhibitor-injected segment, because glial positions in this segment do not appear to be vacated by the extensive migration into adjacent segments. However, glia can migrate from control segments into adjacent segments that lack glia because of engrailed inhibition, and glial positions in the control segment also do not appear to be vacated in this case [7] . Thus, extra glia may be generated when there are vacant positions to fill in adjacent segments.
Similarly, the number of glia in PKA-inhibited segments that are not adjacent to segments with vacant positions may be down-regulated by reducing proliferation of glial precursors in response to the filling of all glial positions within the segment. This would be formally analogous to control of oligodendrocyte number in the rat optic nerve, where glial numbers are regulated by the number of axons that require enwrapping [27] . Oligodendrocyte numbers, however, are regulated primarily by cell death, and we have found no evidence for glial death in control or PKA-inhibited grasshopper segments.
Elevation of PKA activity in the MNB triggers the second (glial-to-neuronal) cell-fate transition in.the MNB lineage, whereas inhibition of engrailed expression in newly born progeny blocks the first (neuronal-to-glial) transition. Inhibition of engrailed and premature elevation of PKA activity produce apparently identical midline phenotypes, because both perturbations convert the midline glia into neurons. Engrailed is apparently required for the acquisition of midline glial fates, as no glia are produced when its expression is inhibited [7] . Acquisition of neuronal fates, however, does not appear to require elevated PKA activity, because many neuronal progeny are generated before 32 % and after 48 % of development, periods during which PKA-C is cytoplasmically localized. Furthermore, the ganglion mother cell progeny that are normally produced during the first neuronal phase are still generated if Walsh inhibitor is injected into the MNB prior to 30 % (data not shown).
Given these results, one would predict that if the MNB nucleus is injected at 32 % with both Walsh inhibitor and antisense-engrailed oligodeoxynucleotides, the lineage should behave identically to an engrailed-inhibited lineage. The loss of engrailed expression converts glial precursors into neurons before the time at which PKA is normally activated in the MNB, so prevention of this activation by Walsh inhibitor should have no additional effect. Figure 5g shows that this is indeed the observed phenotype. The cell-fate decisions in the MNB lineage, and their regulation by PKA and engrailed are summarized in Figure 6 .
PKA activation and cell-fate determination in other systems
To our knowledge, the grasshopper MNB lineage is the only system in which nuclear translocation of PKA-C has been observed in vivo. A number of studies in cultured cells, however, suggest that translocation is a physiologically relevant process. Treatment of Aplysia neurons with serotonin under conditions similar to those that produce long-term facilitation induces PKA-C translocation [12] . Nuclear entry of PKA-C appears to be the rate-limiting step in hormone-stimulated phosphorylation and transcriptional activation of cAMP-binding protein (CREB) transcription factors in rat PC12 cells [28] .
The Drosophila DCO gene encodes a PKA-C subunit that accounts for most PKA activity in adult flies [14] . However, there are two other genes (DC1 and DC2) that could encode other PKA-like catalytic subunits [15] , and it is unknown whether PKA activity in the embryonic CNS is entirely due to the DCO gene product. The embryonic phenotypes caused by DCO mutations are difficult to interpret because of perdurance of the maternally encoded protein, which persists until at least 12 hours post-fertilization. About half of the embryos produced by trans-heterozygous females bearing two weak DCO alleles fail to hatch, and the unhatched embryos display a heterogenous collection of cuticle defects [14] . The nature of the defects suggest that abnormalities develop at an early stage in these embryos (before axonogenesis in the CNS). Thus, it is unclear whether an MNB-lineage phenotype similar to the PKA-inhibition phenotype seen in grasshopper embryos could be observed in DCO mutant fly embryos. Elevation of cAMP levels during Drosophila embryonic development also produces a heterogenous collection of phenotypes that are not easily compared to the effects of premature PKA activation in grasshopper embryos. Embryos produced by mothers bearing dunce mutations (which reduce or eliminate cAMP phosphodiesterase activity) display a wide range of defects, most of which suggest that abnormalities occurred early in development ( [29, 30] and B.G.C., unpublished results).
It has been recently shown that PKA activity can affect cell growth and differentiation events controlled by the Ras pathway. In rat PC12 cells, elevated PKA activity increases MAP kinase activity and can induce neuronal differentiation [31, 32] . This could be relevant to the effects of PKA activity on the glial-to-neuronal decision in the MNB lineage. It is not a general mechanism for neuronal differentiation in insects, however, because large clones of cells homozygous for null DCO alleles can be generated in the Drosophila eye, and the photoreceptor clusters within the clone appear morphologically normal [14] . Thus, PKA activity is not required for function of the Sevenless/Ras pathway, which is necessary for R7 photoreceptor cell determination [33] .
Conclusions
The grasshopper MNB is a multipotent progenitor cell that generates glial and neuronal progeny in distinct temporal phases [2] . The first cell-fate transition (neuronalto-glial) in the MNB lineage requires engrailed function [7] . We have shown that elevation of intracellular cAMP and activation of PKA is a trigger for the second (glialto-neuronal) transition (summarized in Figure 6 ). Glial/neuronal cell-fate decisions are poorly understood in both insects and vertebrates, and no mutations have been shown to affect these decisions in the Drosophila CNS. The recently described sanpodo mutation, however, may convert peripheral nervous system (PNS) glia into neurons [34] . Interestingly, the PNS neuronal clusters in sanpodo embryos are disorganized and laterally expanded, and have a similar appearance to grasshopper MNB clusters that contain extra neurons and lack glia. It will be of interest to identify other genes and pathways that are involved in glial/neuronal decisions within multipotential lineages in the CNS and PNS.
Materials and methods
Immunohistochemistry
Embryo staining with monoclonal antibodies was performed as described [2, 7, 35] , and all embryos were viewed through either a Zeiss Axioplan microscope or a Bio-Rad 600 confocal microscope. Rat anti-Drosophila elav antiserum was provided by Kalpana White (Brandeis University) and used at a dilution of 1:1 500. Rabbit anti-Drosophila PKA-C antiserum was provided by Daniel Kalderon (Columbia University), and was used at a 1:300 dilution. The 8B7 monoclonal antibody was provided by Michael Bastiani (University of Utah).
Quantitation of nuclear translocation
To quantify nuclear translocation of PKA-C in the MNB, fine confocal-derived optical sections of fluorescently stained MNBs at the widest point of the nucleus (at the point of the cytoplasmic intrusion) were taken from a range of embryos at various developmental stages. Each MNB was staged by the development of the CNS in that segment and the overall morphology of the embryo [36] . The total fluoresence intensity of the nucleus and cytoplasm was determined using the program NIH Image by individually marking out the nuclear and cellular boundaries. Nuclear translocation was calculated as the ratio of total nuclear fluorescence to total cytoplasmic fluoresence. Repeated measures of single MNBs indicated that the errors involved in measurement were less than 10 %. Nuclear/cytoplasmic ratios from 81 MNBs were pooled according to their estimated ages. The average and standard deviation was calculated for each and plotted in Figure 3 . Using the StatWorks program, the significance of ratio differences between developmental percentages were calculated according to the Student's t statistic. The significance of certain differences were as follows: 35% versus 39%: 7.32x10-5 ; 33% versus 35%: 0.363; 39% versus. 41%: 0.589. This indicates that a statistically significant difference exists between localization at 35% and at 39%, but there is no statistically significant change in localization between 33% and 35%, or between 39% and 41%.
Embryo cultures and injections
Microinjection and embryo culturing were done as described previously [2, 7] . Embryos were dissected, microinjected or treated with various drugs, cultured for 3 days and then fixed, stained and scored. IBMX and forskolin (RBI) were used at 501 M; R -cAMPS (Calbiochem) was used at 25 p.M; Walsh inhibitor (Sigma) and PKA-C (Promega Biotech) were used at 100 pIM and 50 U p1-l, respectively. 77 embryos were treated with IBMX: 53 displayed dorsalized MNB clusters, 24 did not develop. Seven embryos were treated with forskolin; 6 displayed dorsalized MNB clusters; one did not develop. 13 embryos were treated with Rp-cAMPS: 12 displayed a loss of MNB cluster neurons and excess glia; one was apparently normal. 75 MNBs were injected with Walsh inhibitor: 60 injected segments displayed a loss of MNB cluster neurons and excess glia; 15 appeared normal. 21 MNBs were injected with PKA-C: 17 segments displayed dorsalized MNB clusters; four MNBs died or did not divide. Four MNBs were injected with antisense-engrailed oligodeoxynucleotides (as described in [7] ) and Walsh inhibitor: all injected segments displayed dorsalized MNB clusters. Five MNBs were injected with antisenseengrailed ODNs and cultured in IBMX: all injected segments displayed dorsalized MNB clusters. 14 MNBs were injected with antisense-engrailed oligod ,xynucleotides and the embryo cultured in Rp-cAMPS: 12 injected segments displayed dorsalized MNB clusters; two displayed a loss of MNB cluster neurons and excess glia. 16 MNBs were injected with Walsh inhibitor and the embryo cultured in IBMX: 13 segments displayed a loss of MNB cluster neurons and excess glia; three displayed dorsalized MNB clusters.
